Business Relations Table

Beispiel: brt.php?search=wide&s=wide&p=adjective&o=wideness

BR-Relations: 24

From Domain	Role	To Domain	Path
ir.kitepharma.com	>>isReferenceFrom	seekingoptions.com	/category/business/page/30/
ir.kitepharma.com	>>isReferenceFrom	pianetascience.it	/salute/ancora-conferme-sulla-terapia-genica-in-chiave-anti-tumore/
ir.kitepharma.com	>>isReferenceFrom	notistecnicas.blogspot.com	/2017/03/pacientes-terminales-de-cancer-en.html
ir.kitepharma.com	>>isReferenceFrom	biotechstrategyblog.com	/2015/01/cellectis-ramps-up-car-t-development-in-2015.html/
ir.kitepharma.com	>>isReferenceFrom	cancerology.blogspot.com	/2017/04/car-t-cells-near-market-for-all-and.html
ir.kitepharma.com	>>isReferenceFrom	slingshotinsights.com	/catalysts/659
ir.kitepharma.com	>>isReferenceFrom	bb-bridge.co.jp	/news/2639/
ir.kitepharma.com	>>isReferenceFrom	ida2at.com	/car-t-cell-therapy-against-cancer/
ir.kitepharma.com	>>isReferenceFrom	dciencia.es	/la-inmunoterapia-car-t-nuevas-armas-frente-al-cancer/
ir.kitepharma.com	>>isReferenceFrom	kgov.com	/targeted-antibody-cancer-treatment-revolution
ir.kitepharma.com	>>isReferenceFrom	technewslit.com	/sciencebusiness/
ir.kitepharma.com	>>isReferenceFrom	yearinreview.h5mag.com	/year_in_review_2015/a_glance_of_the_sector
ir.kitepharma.com	>>isReferenceFrom	propthink.com	/ash-2014-abstracts-hit-names-follow/
ir.kitepharma.com	>>isReferenceFrom	3sixtypharma.com	/2016/06/02/genetically-modified-t-cell-therapy/
ir.kitepharma.com	>>isReferenceFrom	dcatvci.org	/top-industry-news/gilead-to-acquire-kite-pharma-for-11-9-billion/
ir.kitepharma.com	>>isReferenceFrom	biostock.se	/2017/03/kraftig-marknadstillvaxt-for-sarlakemedel-2017-2022/
ir.kitepharma.com	>>isReferenceFrom	biopharminternational.com	/novartis-kite-release-positive-car-t-data-0
ir.kitepharma.com	>>isReferenceFrom	insights.bio	/cell-and-gene-therapy-insights/journal/article/419/toward-an-integrated-model-of-product-characterization-for-cart-cell-therapy-drug-development-efforts
ir.kitepharma.com	>>isReferenceFrom	medmix.at	/axicabtagen-ciloleucel-refraktaerem-aggressivem-non-hodgkin-lymphom/
ir.kitepharma.com	>>isReferenceFrom	endpoints.news	/kite-grabs-a-stem-cell-biology-breakthrough-in-race-for-off-the-shelf-t-cell-therapies/

1 2 Nächste

Business Relations Table - o4.fyi ()

BR-Editor

Domain-Statistiken für "ir.kitepharma.com"

BR-Relations: 24